Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed · Phase 2

Conditions studied: Open-Angle Glaucoma, Ocular Hypertension

In brief

The purpose of thie study is to compare the safety and IOP-lowering efficacy of AL-37807 Ophthalmic Solution 0.05%, 0.1% and 0.2% dosed QD AM to Xalatan dosed QD PM and Vehicle in patients with open-angle glaucoma or ocular hypertension

Key facts

Study ID

NCT00465621

Run by

Alcon Research

People needed

150

Starts

2007-03-01

Last updated by the study team

2008-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Open-angle glaucoma
• ocular hypertension

You may not qualify if…

• VA worse than 0.60

Where it is running

• Atlanta — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.